(Q28198048)

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

The receptor tyrosine kinase ARK mediates cell aggregation by homophilic binding

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Human growth hormone and extracellular domain of its receptor: crystal structure of the complex

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Structure of a heparin-linked biologically active dimer of fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Shc Binding to Nerve Growth Factor Receptor Is Mediated by the Phosphotyrosine Interaction Domain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

The ephrins and Eph receptors in neural development

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

A highly conserved tyrosine residue at codon 845 within the kinase domain is not required for the transforming activity of human epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

A model for the activation of the epidermal growth factor receptor kinase involvement of an asymmetric dimer?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

The protein kinase family: conserved features and deduced phylogeny of the catalytic domains

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Dimerization of cell surface receptors in signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Cell-contact-dependent signalling in axon growth and guidance: Eph receptor tyrosine kinases and receptor protein tyrosine phosphatase beta

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Crystal structure of the tyrosine kinase domain of the human insulin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Autoregulatory mechanisms in protein-tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Interaction between the phosphotyrosine binding domain of Shc and the insulin receptor is required for Shc phosphorylation by insulin in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Active and inactive protein kinases: structural basis for regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Localization of a major receptor-binding domain for epidermal growth factor by affinity labeling

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Two EGF molecules contribute additively to stabilization of the EGFR dimer

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Kit receptor dimerization is driven by bivalent binding of stem cell factor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Tyrosine kinase inhibition: an approach to drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Identification of the major autophosphorylation sites of Nyk/Mer, an NCAM-related receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

An epidermal growth factor receptor/Jak2 tyrosine kinase domain chimera induces tyrosine phosphorylation of Stat5 and transduces a growth signal in hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Protein modules and signalling networks

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

A chimaeric receptor allows insulin to stimulate tyrosine kinase activity of epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Self-phosphorylation of epidermal growth factor receptor is an intermolecular reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

YMXM motifs of IRS-1 define substrate specificity of the insulin receptor kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Strong hydrogen bonding interactions involving a buried glutamic acid in the transmembrane sequence of the neu/erbB-2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Trk receptors use redundant signal transduction pathways involving SHC and PLC-gamma 1 to mediate NGF responses

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Neu receptor dimerization

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Crystal structure of three consecutive laminin-type epidermal growth factor-like (LE) modules of laminin gamma1 chain harboring the nidogen binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Three protein kinase structures define a common motif

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

How do protein kinases discriminate between serine/threonine and tyrosine? Structural insights from the insulin receptor protein-tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

An Epidermal Growth Factor Receptor-Leukocyte Tyrosine Kinase Chimeric Receptor Generates Ligand-dependent Growth Signals through the Ras Signaling Pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Signal transduction by receptors with tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Expression, characterization, and crystallization of the catalytic core of the human insulin receptor protein-tyrosine kinase domain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Two chimeric receptors of epidermal growth factor receptor and c-Ros that differ in their transmembrane domains have opposite effects on cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Catalytic specificity of protein-tyrosine kinases is critical for selective signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

Mutations of Ros differentially effecting signal transduction pathways leading to cell growth versus transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6107%2898%2900047-9

7 January 2021

10.1016/S0079-6107(98)00047-9

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

10354703

1 reference

Consolidated OpenCitations Corpus – April 2017